Last reviewed: June 7, 2026
Last updated: June 7, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide has emerged as a transformative medication for weight management, with clinical trials demonstrating an average weight loss of 15% in people with obesity. This injectable GLP-1 agonist works by mimicking a natural hormone that controls hunger, satiety, and blood sugar levels. PlexusDx provides access to compounded semaglutide from licensed 503A pharmacies, starting at $149 per month with no insurance required.
How Semaglutide Works for Weight Loss
Semaglutide activates GLP-1 receptors located throughout your digestive system and brain. When these receptors are stimulated, they send signals that slow gastric emptying—the rate at which food leaves your stomach. This delayed emptying creates a prolonged sensation of fullness, reducing the urge to eat between meals and at mealtime. The result is naturally lower calorie intake without the constant battle against hunger.
Beyond appetite suppression, semaglutide influences the brain's satiety centers, particularly the hypothalamus, which regulates energy balance and feeding behavior. By enhancing these neural pathways, the medication helps you feel satisfied with smaller portions. This dual mechanism—peripheral and central nervous system effects—makes semaglutide uniquely effective compared to older weight loss approaches that relied on stimulants alone.
Clinical Evidence for Semaglutide Weight Management
The STEP trials, the largest clinical studies on semaglutide for weight loss, tracked over 4,500 adults across multiple years. Participants receiving semaglutide lost an average of 10 to 15 percent of their baseline body weight, with some achieving 20 percent reductions. In comparison, the placebo group lost only 2 to 3 percent. These results held steady over 68 weeks, demonstrating that semaglutide's effects are both significant and durable when taken consistently.
Real-world data from primary care settings shows similar outcomes, with weight reductions often appearing within 4 to 8 weeks of starting treatment. Improvements in metabolic markers—including fasting glucose, HbA1c, and triglycerides—frequently accompany weight loss, even independent of the pounds shed. This suggests semaglutide offers metabolic benefits beyond cosmetic weight reduction.
Semaglutide Injection vs. Oral Formulations
PlexusDx offers both semaglutide injection and oral semaglutide to match your lifestyle and preferences. Injectable semaglutide is administered once weekly subcutaneously and typically produces more consistent dose delivery and absorption compared to oral formulations. Many patients prefer injections because they require only one weekly dose, simplifying adherence and reducing the number of daily pills.
Oral semaglutide, by contrast, is taken daily and appeals to patients who prefer avoiding injections. Both formulations are compounded by PlexusDx's licensed 503A pharmacies and start at $149 per month for injections and $249 per month for oral tablets. Your dose may need to go up as your provider titrates you upward, but your price won't change—PlexusDx maintains flat monthly pricing across all dose levels.
Personalization With Genetic Insights
Individual responses to semaglutide vary considerably, with some people experiencing rapid weight loss while others progress more gradually. PlexusDx's Precision Peptide Genetic Test identifies key genetic variants that influence GLP-1 pathway sensitivity and metabolic rate. The test examines markers such as GLP1R rs6923761, GIPR rs1800437, FTO rs9939609, and MC4R rs17782313—genes directly involved in how your body responds to GLP-1 therapy.
By mapping 14 distinct metabolic pathways across 49 peptides and 150+ genetic insights, PlexusDx helps your provider optimize your semaglutide dose and predict which formulation (injection vs. oral) may work best for your biology. The Precision Peptide test costs $99 as an add-on after your first month of treatment and integrates seamlessly with your personalized weight loss plan. This precision approach transforms semaglutide from a one-size-fits-all medication into a truly tailored therapy.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
How quickly will I lose weight on semaglutide?
Most people begin noticing weight loss within 4 to 8 weeks of starting semaglutide, though full effects emerge over 12 to 16 weeks as your provider adjusts your dose. Individual timelines vary based on starting weight, diet, activity level, and genetic factors. PlexusDx's Precision Peptide Genetic Test can help predict your likely response pattern.
Does semaglutide work for everyone?
Semaglutide is effective for most people, but response rates and speed vary significantly due to genetic differences in GLP-1 receptor sensitivity. Clinical trials show approximately 75% of participants achieve meaningful weight loss (5% or more of baseline weight). PlexusDx's genetic testing identifies your individual peptide pathways to optimize your chances of success.
What is the cost of semaglutide at PlexusDx?
PlexusDx compounded semaglutide injection starts at $149 per month, while oral semaglutide begins at $249 per month. No insurance is required, and all formulations are HSA/FSA eligible. Your dose may increase over time, but PlexusDx's flat monthly pricing means your cost remains the same regardless of dose level.
What are the common side effects of semaglutide?
The most frequent side effects are mild nausea, vomiting, diarrhea, and constipation—most of which resolve within a few days to weeks as your body adjusts. Serious side effects are rare and include pancreatitis, gallbladder issues, and thyroid concerns; report any severe abdominal pain or persistent vomiting to your provider immediately. PlexusDx medications are compounded by licensed 503A pharmacies and provided under physician supervision for safety monitoring.
Can the Precision Peptide Genetic Test predict my weight loss with semaglutide?
Yes. The Precision Peptide test identifies your GLP1R and GIPR genetic variants, which directly influence how strongly you respond to semaglutide stimulation. The test also examines appetite-regulation genes like FTO and MC4R. Combined with your provider's clinical assessment, these 150+ genetic insights help predict your likely weight loss magnitude and optimal semaglutide dosing strategy.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Is It Safe to Get Semaglutide from a Compounding Pharmacy?
Exploring Phentermine and Ozempic®: Can You Take Both for Weight Loss?